Brenda Blackmon

Cantor Fitzgerald LP provides brokerage services. It offers capital market, investment banking and portfolio business services. The company was founded in 1945 and is headquartered in New York, NY.

BGC Partners LP is a broker/dealer located in New York City. The firm is a subsidiary of BGC Partners, Inc. (NASDAQ: BGCP), a leading global intermediary to the wholesale financial markets, specializing in the brokering of a broad range of financial products including fixed-income, rates, foreign exchange, equity derivatives, credit derivatives, futures and structured product markets. Previously a subsidiary of Cantor Fitzgerald, BCG separated from that firm in 2004. In 2005, BGC merged with Maxcor Financial Group, integrating two leading brokerage firms. This was followed by the acquisitions of ETC Pollak and Aurel in Paris. On April 1, 2008, BGC merged with eSpeed to form a world-class provider of voice and electronic brokerage services in the global marketplace. The combined company is BGC Partners, Inc. (NASDAQ: BGCP). BGC offers a full range of brokerage services including price discovery, trade execution, straight through processing and clearing, settlement and access to electronic trading services through its eSpeed and BGC Trader brands.

The Johnson Co., Inc. functions as a private investment firm. The private company is based in New York, NY.

Trotana, Inc. discovers and develops medicines. The company is based in San Diego, CA. The CEO of the company is Hamza Suria.

Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning.

Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA.

ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin.

Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA.

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

BGC Partners, Inc. engages in the provision of brokerage services to the financial markets. The firm offers integrated voice, hybrid and fully electronic brokerage in a broad range of products, including fixed income, foreign exchange, equities, insurance, energy and commodities and futures. It also provides trade execution, brokerage, clearing, trade compression, post-trade, information and other back-office services. The company was founded in 1945 and is headquartered in New York, NY.

ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA.

Vanderbilt Vascular Biology Center operates a biology center. The private company is based in Nashville.

Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA.

Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA.

The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA.

Part of Venterra Group Plc, INSPIRE Environmental LLC is a marine environmental science company based in Newport, RI. INSPIRE Environmental's skilled team of scientists is dedicated to making marine environmental science understandable by applying innovative technology for effective solutions. The company was founded in 2015 by Drew A. Carey, Joe Germanotta. Drew A. Carey has been the CEO since 2015. INSPIRE Environmental was acquired by Venterra Group Plc on July 19, 2022.

Children's Hospital Colorado Foundation provides family centered care to children. It offers treatment to building kids’ confidence through hospital sports program, providing family sleep rooms and integrating arts therapy into the healing process. The company was founded in 1978 and is headquartered in Aurora, CO.

Lugano Diamonds & Jewelry, Inc. designs and manufactures jewellery. Its products include rings, earrings, necklaces, bracelets and brooches. The company was founded by Moti Ferder and is headquartered in Newport Beach, CA.

Orange County Performing Art Center provides music, dance and theater to the people. The company was founded on sep 29th, 1986 and is headquartered in Costa Mesa, CA.

The Lionstone Group is an Independent Private Equity firm founded in 2001. The Lionstone Group is headquartered in Houston.

Blackstone Real Estate Advisors LP (Blackstone Real Estate) is a private equity firm, a subsidiary of Blackstone Holdings Partnerships founded in 1991 by John G. Schreiber. The firm is headquartered in New York.

Solamere Capital LLC (Solamere Capital) is a private equity firm founded in 2008 by Tagg Romney, Eric scheuermann and Spencer Zwick. The firm is headquartered in Boston, Massachusetts.

Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021.